Document is current
Any future updates will be listed below
-
Authors
Li, Xiaoxi
Su, Nan
Yu, Haining
Li, Xiaoyan
Sun, Shu-lan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82202861)
Fundamental Research Funds for the Central University (LD202209/LD202024 /LD202115)
Science and Technology Foundation of Liaoning Province (2023-MS-058)
Beijing Xisike Clinical Oncology Research Foundation (Y-tongshu2021/ms-0270)
Outstanding Youth Foundation of Liaoning (2022-YQ-08 to SL. S)
Science and Technology Plan Project of Liaoning (2021-YGJC-22)
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 30 June 2024
First Online: 5 July 2024
Declarations
:
: Registry and Registration No. of this study: This study was approved by the Ethics Committee of the Liaoning Cancer Hospital (NO: 20210823YG). Informed consent was provided by all the participants. This study was performed in accordance with the Declaration of Helsinki. All the animal study procedures were performed according to protocols approved by China Medical University’s Institutional Committee for the Use and Care of Laboratory Animals. All the methods were carried out in accordance with the relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines.
: All the authors have read the manuscript and agreed with its publication.
: The authors declare no competing interests.
